Status: current, Defined. Date: 31-Jan 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3019731000168116 | Optimark (gadoversetamide 4.96 g / 15 mL) injection, 1 x 15 mL syringe (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3019741000168113 | Optimark 4.96 g/15 mL injection, 15 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Optimark 4.96 g/15 mL injection, 15 mL syringe | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Optimark 4.96 g/15 mL injection, 15 mL syringe | Is a | Optimark 4.96 g/15 mL injection, 15 mL syringe | true | Inferred relationship | Some | ||
| Optimark 4.96 g/15 mL injection, 15 mL syringe | has container type | syringe | true | Inferred relationship | Some | ||
| Optimark 4.96 g/15 mL injection, 15 mL syringe | has TPUU | Optimark 4.96 g/15 mL injection, 15 mL syringe | true | Inferred relationship | Some | 1 | |
| Optimark 4.96 g/15 mL injection, 15 mL syringe | has TP | Optimark | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR